Lumizyme
Generic name: Alglucosidase Alfa (injection)
Brand names: Lumizyme
Drug class:
Lysosomal enzymes
Usage of Lumizyme
Lumizyme contains an enzyme that naturally occurs in the body in healthy people. Some people lack this enzyme because of a genetic disorder. Alglucosidase alfa helps replace this missing enzyme in such people.
Lumizyme is used to treat a glycogen storage disorder called Pompe disease, (also called GAA deficiency) in adults and children.
Lumizyme may also be used for purposes not listed in this medication guide.
Lumizyme side effects
Get emergency medical help if you have signs of an allergic reaction to Lumizyme: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Some allergic reactions may occur during the injection, or as long as 3 hours afterward. Tell your caregivers or get emergency medical help right away if you have:
Also call your doctor at once if you have:
Common Lumizyme side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Lumizyme
To make sure Lumizyme is safe for you, tell your doctor if you have ever had:
Babies who develop Pompe disease in the first year of life may need specialized medical tests to improve treatment with Lumizyme treatment.
It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
You should not breastfeed within 24 hours after receiving Lumizyme. If you use a breast pump during this time, throw out any milk you collect. Do not feed it to your baby.
Your name may be listed on the Pompe Registry. This is to track the progress of your disease and the outcome of your treatment with Lumizyme.
Relate drugs
- Agalsidase beta
- Aldurazyme
- Alglucerase
- Alglucosidase alfa
- Avalglucosidase alfa
- Avalglucosidase alfa-ngpt
- Myozyme
- Brineura
- Ceredase
- Cerezyme
- Cerliponase alfa
- Elaprase
- Elelyso
- Elfabrio
- Elosulfase alfa
- Fabrazyme
- Galsulfase
- Idursulfase
- Imiglucerase
- Kanuma
- Lamzede
- Laronidase
- Lumizyme
- Mepsevii
- Naglazyme
- Nexviazyme
- Olipudase alfa
- Olipudase alfa-rpcp
- Pegunigalsidase alfa-iwxj
- Pombiliti
- Sebelipase alfa
- Taliglucerase alfa
- Velaglucerase alfa
- Velmanase alfa-tycv
- Vestronidase alfa
- Vestronidase alfa-vjbk
- Vimizim
- VPRIV
- Xenpozyme
How to use Lumizyme
Usual Adult Dose for Pompe disease:
20 mg/kg via IV infusion every 2 weeks Comments: -Total volume of infusion is determined by patient's body weight and should be infused over about 4 hours.
Usual Pediatric Dose for Pompe disease:
20 mg/kg via IV infusion every 2 weeks Comments: -Total volume of infusion is determined by body weight and should be infused over about 4 hours.
Warnings
Some people receiving Lumizyme have had serious allergic reactions during or shortly after infusion of this medicine.Tell your caregivers or get emergency medical help right away if you have any signs of a severe allergic reaction, such as itching, rash, redness or tingling, severe headache, feeling light-headed, fast or slow heart rate, wheezing, trouble breathing, pale skin, and blue lips or fingernails.
Before receiving Lumizyme, tell your doctor if you have heart disease, lung disease or a breathing disorder, or if you are allergic to mice, hamsters, or drug products made with "murine" proteins.
Before each injection, tell your doctor if you have recently been sick with a cold, flu, or other illness. Some people receiving an injection of Lumizyme have had a reaction to the infusion. This type of reaction can occur when the medicine is injected into the vein, or as long as 3 hours after the injection.
What other drugs will affect Lumizyme
Other drugs may interact with alglucosidase alfa, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions